A nationwide analysis of antibiotic use in hospice care in the final week of life
- PMID: 23317761
- PMCID: PMC3723720
- DOI: 10.1016/j.jpainsymman.2012.09.010
A nationwide analysis of antibiotic use in hospice care in the final week of life
Abstract
Context: Antibiotic prescription in hospice patients is complicated by the focus on palliative rather than curative care and concerns regarding increasing antibiotic resistance.
Objectives: To estimate the antibiotic use in a national sample of hospice patients and identify facility and patient characteristics associated with antibiotic use in this population.
Methods: This was an analysis of data from the 2007 National Home and Hospice Care Survey, a nationally representative sample of U.S. hospice agencies. We included data from 3884 patients who died in hospice care. The primary outcome measure was prevalence of antibiotic use in the last seven days of life. Diagnoses, including potential infectious indications for antibiotic use, were defined using International Classification of Diseases, Ninth Revision (ICD-9) codes. Chi-squared tests and t-tests were used to quantify associations of patient and facility characteristics with antibiotic use.
Results: During the last seven days of life, 27% (95% CI: 24%-30%) of patients received at least one antibiotic and 1.3% (95% CI: 0.7%-2.0%) received three or more antibiotics. Among patients who received at least one antibiotic, 15% (95% CI: 10%-20%) had a documented infectious diagnosis compared with 9% (95% CI: 7%-11%), who had an infectious diagnosis but received no antibiotics.
Conclusion: In this nationally representative sample, 27% of hospice patients received an antibiotic during the last seven days of life, most without a documented infectious diagnosis. Further research is needed to elucidate the role of antibiotics in this patient population to maintain palliative care goals while reducing unnecessary antibiotic use.
Keywords: Hospice; NHHCS; antibiotics; infection.
Copyright © 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Clinical Intentions of Antibiotics Prescribed Upon Discharge to Hospice Care.J Am Geriatr Soc. 2018 Mar;66(3):565-569. doi: 10.1111/jgs.15246. Epub 2018 Jan 18. J Am Geriatr Soc. 2018. PMID: 29345756 Free PMC article.
-
Infections in long-term care populations in the United States.J Am Geriatr Soc. 2013 Mar;61(3):342-9. doi: 10.1111/jgs.12153. J Am Geriatr Soc. 2013. PMID: 23496650
-
Intensive palliative care for patients with hematological cancer dying in hospice: analysis of the level of medical care in the final week of life.Am J Hosp Palliat Care. 2015 Mar;32(2):221-5. doi: 10.1177/1049909113512412. Epub 2013 Nov 20. Am J Hosp Palliat Care. 2015. PMID: 24259405
-
The National Home and Hospice Care Survey: 1994 summary.Vital Health Stat 13. 1997 Feb;(126):1-124. Vital Health Stat 13. 1997. PMID: 9123894 Review.
-
A review of barriers to utilization of the medicare hospice benefits in urban populations and strategies for enhanced access.J Urban Health. 2008 Mar;85(2):281-90. doi: 10.1007/s11524-008-9258-y. J Urban Health. 2008. PMID: 18240022 Free PMC article. Review.
Cited by
-
The Use of Antibiotics at the End of Life: A Cross-Sectional Study.Health Serv Insights. 2024 Sep 15;17:11786329241280812. doi: 10.1177/11786329241280812. eCollection 2024. Health Serv Insights. 2024. PMID: 39286265 Free PMC article.
-
Ethical and Practical Issues with the Use of Antimicrobial Agents during the End of Life.J Hosp Palliat Care. 2024 Sep 1;27(3):99-102. doi: 10.14475/jhpc.2024.27.3.99. J Hosp Palliat Care. 2024. PMID: 39268047 Free PMC article.
-
Infection on Frail Patients in the Intensive Care Unit: Insights From the PalMuSIC Study.Cureus. 2024 Jul 5;16(7):e63897. doi: 10.7759/cureus.63897. eCollection 2024 Jul. Cureus. 2024. PMID: 39099977 Free PMC article.
-
Improving shared decision-making around antimicrobial-prescribing during the end-of-life period: a qualitative study of Veterans, their support caregivers and their providers.Antimicrob Steward Healthc Epidemiol. 2024 May 17;4(1):e89. doi: 10.1017/ash.2024.61. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 38774117 Free PMC article.
-
Frontiers in antimicrobial stewardship: antimicrobial use during end-of-life care.Antimicrob Steward Healthc Epidemiol. 2023 Oct 2;3(1):e164. doi: 10.1017/ash.2023.207. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 38028928 Free PMC article. No abstract available.
References
-
- National Hospice and Palliative Care Organization . NHPCO facts and figures: Hospice care in America. NHPCO; Alexandria, VA: Sep, 2010.
-
- Hospice Association of America . Hospice facts and statistics. Hospice Association of America; Washington, DC: Nov, 2010.
-
- Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage. 2000;20(5):326–334. - PubMed
-
- Ford P, Fraser T, Davis M, Kodish E. Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients. Bioethics. 2005;19(4):379–392. - PubMed
-
- Hutcheson A. Hospice care in the United States. Prim Care. 2011;38(2):173–182. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
